Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
Recombinant Adenoviral vectors represent one of the best gene transfer platforms due to their ability to efficiently transduce a wide range of quiescent and proliferating cell types from various tissues and species.The activation of an adaptive immune response against the transduced cells is one of the major drawbacks of first generation Adenovirus